Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 21
Selected: 0
NCT IDTitle
NCT00349466Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT02647762CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis
NCT00428974Safety and Efficacy Study of CF101 to Treat Psoriasis
NCT00790673A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1
NCT06643260A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
NCT05201404Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
NCT00556894Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
NCT04697810Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
NCT04333472Piclidenoson for Treatment of COVID-19
NCT01033422Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
NCT00280917Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
NCT02128958Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
NCT01905124Safety &Efficacy of CF101 to Subjects With Uveitis
NCT01265667Trial of CF101 to Treat Patients With Psoriasis
NCT00837291A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee
NCT01235234Trial of CF101 to Treat Patients With Dry Eye Disease
NCT00790218A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma
NCT01034306Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis
NCT02927314A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
NCT06387342Namodenoson Treatment of Advanced Pancreatic Cancer
NCT03168256CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis